Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Ferree

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
With modern imaging techniques, is staging laparotomy necessary in pediatric Hodgkin's disease? A Pediatric Oncology Group studyN P Mendenhall, A B Cantor, J L Williams, et al.
The New England Journal of Medicine|May 5, 1994
Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinomaW C Wood, D R Budman, A H Korzun, et al.
Journal of the National Cancer Institute|August 27, 1998
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group BD R Budman, D A Berry, C T Cirrincione, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
With modern imaging techniques, is staging laparotomy necessary in pediatric Hodgkin's disease? A Pediatric Oncology Group studyN P Mendenhall, A B Cantor, J L Williams, et al.
The New England Journal of Medicine|May 5, 1994
Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinomaW C Wood, D R Budman, A H Korzun, et al.
Journal of the National Cancer Institute|August 27, 1998
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group BD R Budman, D A Berry, C T Cirrincione, et al.
Pageof 2